Rhythm Pharmaceuticals, Inc. RYTM Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s accounts payable?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported accounts payable of $12.3M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s accounts payable increased by 3.2% year-over-year, from $11.91M to $12.3M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s accounts payable has grown at a 23.3% compound annual growth rate (CAGR), from $4.9M to $13.95M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.